VIVO CAPITAL
The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists, entrepreneurs, operating executives, and industry experts. The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.
VIVO CAPITAL
Social Links:
Industry:
Finance Financial Services Health Care Venture Capital
Founded:
1996-01-01
Status:
Active
Contact:
(650) 688-0818
Email Addresses:
[email protected]
Technology used in webpage:
U.S. Server Location
Similar Organizations
Carson Capital
Carson Capital is an investment firm that is looking to build something special and help steward a business’ growth into the future.
Johnson & Johnson Innovation – JJDC
JJDC finds transformative ideas and helps them mature into real solutions for today’s patients.
New Enterprise Associates
New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Optum Ventures
Optum Ventures provides capital and strategic guidance to startup companies solving health care's pressing challenges.
Pangaea Ventures
Pangaea Ventures invests in companies solving fundamental problems in the world with advanced materials and hard technology; Impact Investor
SR One
SR One is the corporate venture capital arm of GlaxoSmithKline.
SS&C Technologies
SS&C is a global provider of investment and financial software-enabled services and software focused exclusively on the global financial
TCG Crossover
TCG Crossover is a healthcare investment firm dedicated to advancing disruptive medicines and supporting companies.
Valor Capital Group
Valor is an investment firm that focuses on cross-border financial and investment opportunities.
Valor Equity Partners
Valor Equity Partners is an operational growth investment firm that focuses on growth companies across various stages of development.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-08 | Serán Bioscience | Serán Bioscience acquired by Vivo Capital | N/A |
| 2016-12-19 | Angiotech Pharmaceuticals | Angiotech Pharmaceuticals acquired by Vivo Capital | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-05-30 | Celcuity | Vivo Capital investment in Post-IPO Equity - Celcuity | 60 M USD |
| 2024-05-13 | Ajax Therapeutics | Vivo Capital investment in Series C - Ajax Therapeutics | 95 M USD |
| 2024-05-07 | Zenas BioPharma | Vivo Capital investment in Series C - Zenas BioPharma | 200 M USD |
| 2024-05-03 | Abeona Therapeutics | Vivo Capital investment in Post-IPO Equity - Abeona Therapeutics | 75 M USD |
| 2024-03-20 | Clasp Therapeutics | Vivo Capital investment in Series A - Clasp Therapeutics | 150 M USD |
| 2024-03-19 | Geron | Vivo Capital investment in Post-IPO Equity - Geron | 150 M USD |
| 2024-03-14 | Unicycive Therapeutics | Vivo Capital investment in Post-IPO Equity - Unicycive Therapeutics | 50 M USD |
| 2024-03-12 | Regulus Therapeutics | Vivo Capital investment in Post-IPO Equity - Regulus Therapeutics | 100 M USD |
| 2024-02-06 | Attralus | Vivo Capital investment in Series B - Attralus | 56 M USD |
| 2024-02-05 | Adverum Biotechnologies | Vivo Capital investment in Post-IPO Equity - Adverum Biotechnologies | 127.5 M USD |
Newest Events participated
More informations about "Vivo Capital"
Vivo Capital - Wikipedia
Vivo has three strategies, Private equity, Public equity and Venture capital. Vivo historically has invested 70% of its capital into biotechnology companies and 30% into medical device …See details»
Our Team – Vivo Capital | Healthcare Focused Investment Firm
Qi Zhu is the Head of Talent and Organization Development at Vivo Capital. She oversees Vivo’s Human Resource matters and aligns the global talent strategies with the organization’s overall …See details»
Vivo Capital - Crunchbase Investor Profile & Investments
The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, …See details»
Vivo Capital - Org Chart, Teams, Culture & Jobs - The Org
Founded in 1996, Vivo Capital is a global investment firm focused on healthcare. Vivo has approximately $4.3 billion in assets under management, invested in over 250 public and private companies worldwide. The firm is headquartered in …See details»
Vivo Capital
Vivo Capital is a healthcare focused investment firm formed in 1996 with over $1.7 billion under management. Vivo Capital is currently making investments from its $750M eighth fund into …See details»
Vivo Capital - Leadership Team - The Org
The Leadership Team at Vivo Capital plays a crucial role in shaping the firm’s strategic direction and investment strategy in the healthcare sector. Comprising experienced professionals, they …See details»
Vivo Capital - Investment Associates - The Org
The Investment Associates team at Vivo Capital plays a pivotal role in identifying, analyzing, and executing investment opportunities in the healthcare sector. Comprised of various levels of …See details»
Vivo Capital: Insights into Strategy and Investment Focus - CGAA
Another example is the Vivo Capital Fund IX, which closed in October 2019 with a staggering $1.43 billion in funding, making it a substantial investment in the venture capital space. The …See details»
Vivo Capital | Institution Profile | Private Equity International
Vivo Capital raises $1.43bn. The Palo Alto-based private equity firm closed its ninth healthcare and life sciences fund above its target. Get access to all Vivo Capital news and analysis > Vivo …See details»
About – Vivo Capital | Healthcare Focused Investment …
Jun 19, 2014 BDF Fund (the predecessor of Vivo Capital) was formed by Dr. Frank Kung and Dr. Edgar Engleman in Palo Alto, United States, focused on biotech venture investments. 2000. Early explorations in Asia healthcare …See details»
Vivo Capital | Info, Investments & Portfolio Companies - Gilion
See Vivo Capital's investments, focus and information on the global vc mapping. Exits: 80, Investments: 172 > VC FIRMS > Vivo Capital. Vivo Capital. Founded: 1996. Investments: 172. …See details»
Vivo Capital Files Lawsuits to Protect Sinovac Shareholders
6 days ago Vivo Capital, a leading global investment firm focused exclusively on healthcare and life sciences, today announced multiple legal proceedings to challenge the irresponsible …See details»
Vivo Capital - MAGNiTT
Founded in 1996, Vivo Capital is a global investment firm focused on healthcare. Vivo has approximately $5.4 billion in assets under management, invested in over 250 public and …See details»
Vivo Capital - Investments, Portfolio & Company Exits - Crunchbase
Vivo Capital 's most notable exits include Zenas BioPharma, BioAtla, and Harmony Biosciences. Vivo Capital has acquired 2 organizations. Their most recent acquisition was Serán Bioscience …See details»
Vivo Capital - Private Equity Investments & Executives
See Vivo Capital's 165 investments, 26 executives, and complete investor profile. Founded in 1996, Vivo Capital (formerly BioAsia Investments) is a healthcare investment firm focused on …See details»
Vivo Capital
Jan 14, 2025 Founded in Palo Alto, California in 1996, Vivo Capital is a leading global healthcare investment firm managing approximately $5.8 billion in assets. The firm has invested in …See details»
Vivo Capital - fintechwithoutborders.org
Vivo Capital Investments, Sectors and Contact Details. Vivo Capital. Vivo is a global investment firm focused on healthcare with approximately $5.8 billion in AUM. Location. United States. …See details»
Vivo Capital Files Lawsuits to Protect Sinovac ... - Morningstar
6 days ago Founded in 1996, Vivo Capital is a leading global healthcare investment firm with a diverse, multi-fund investment platform spanning venture capital, growth equity, buyout, and …See details»
SINOVAC Board Issues Letter to Shareholders to Set the Record …
1 day ago 2025: Vivo Capital is taking legal action to attempt to stop the Board from paying SINOVAC shareholders the corrective special cash dividend of US$55.00 per common share …See details»
Botafogo x Capital-DF: onde assistir ao vivo, horário e escalações
2 hours ago O Capital teve problemas para voltar a Brasília depois da vitória sobre o Porto Velho. O voo que traria o time à cidade foi cancelado, o que atrasou o retorno da delegação à …See details»